Related Experiment Video
Updated: Feb 5, 2026

Development of a Larval Zebrafish Infection Model for Clostridioides difficile
Published on: February 14, 2020
MELD is the only predictor of short-term mortality in cirrhotic patients with C. difficile infection
Simon J Hong1, Paul Feuerstadt2, Lawrence J Brandt1
1Division of Gastroenterology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY, United States.
Background:
Clostridium difficile infection (CDI) is the most common nosocomial infection in the US and cirrhotic patients with CDI have increased risk for poor outcome.
Aim:
The aim of this study is to evaluate the impact of CDI on short-term mortality in patients with cirrhosis and identify predictors of mortality in these patients.
Methods:
We retrospectively identified patients at Montefiore Medical Center from 2010 to 2014 with cirrhosis, diarrhea and a C. difficile toxin assay. Demographics, co-morbidities, medications, laboratory data and outcomes were recorded.
Results:
Of 701 patients with cirrhosis who had a CDI assay, 183 were CDI+ and 518 CDI-. Patients with CDI were older, had more frequent CKD on hemodialysis and heart failure, were less frequently on rifaximin and lactulose and had increased glucocorticoid exposure. 30-day mortality was higher in patients with CDI (23.0% vs 16.6%, p < 0.05) compared to those without. Univariate predictors of 30-day mortality included WBC, corticosteroid use, AST, ALT, MELD, albumin, HBV and HCV infection; however, via multivariate analysis, only MELD (HR: 1.04 ± 0.02, p < 0.05) remained significant.
Conclusion:
Patients with cirrhosis and CDI are at greater risk of 30-day mortality than those without CDI and the only multivariate predictor of mortality is MELD. These patients should have their disease severity triaged based upon MELD score.
Insights
Patients with cirrhosis and Clostridium difficile infection (CDI) face higher short-term mortality. The Model for End-Stage Liver Disease (MELD) score is the sole predictor of this increased risk.
Area of Science:
- Hepatology
- Infectious Diseases
- Critical Care Medicine
Background:
- Clostridium difficile infection (CDI) is a prevalent nosocomial infection in the US.
- Cirrhotic patients with CDI exhibit a significantly increased risk of adverse outcomes.
- Understanding CDI's impact on cirrhosis patients is crucial for improving clinical management.
Purpose of the Study:
- To assess the effect of CDI on short-term mortality in patients with cirrhosis.
- To identify key predictors of mortality among cirrhotic patients diagnosed with CDI.
Main Methods:
- Retrospective analysis of cirrhotic patients with diarrhea and C. difficile toxin assay at Montefiore Medical Center (2010-2014).
- Data collection included demographics, comorbidities, medications, laboratory values, and outcomes.
- Statistical analysis to compare outcomes between CDI-positive and CDI-negative groups and identify mortality predictors.
Main Results:
- Of 701 patients, 183 had CDI. CDI patients were older and had more comorbidities like CKD and heart failure.
- Thirty-day mortality was higher in the CDI group (23.0%) compared to the non-CDI group (16.6%).
- Multivariate analysis identified the Model for End-Stage Liver Disease (MELD) score as the only significant predictor of 30-day mortality (HR: 1.04).
Conclusions:
- Cirrhotic patients with CDI face a greater risk of 30-day mortality.
- The MELD score is the primary independent predictor of mortality in this population.
- Disease severity stratification using MELD scores is recommended for managing cirrhotic patients with CDI.
Related Concept Videos
Long-term Depression
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Short-distance Transport of Resources
Power System Three-Phase Short Circuits
Long-term Potentiation
Long-term Potentiation
Hebbian LTP
LTP can occur when...

